Location, location, location: Gastrointestinal delivery site and its impact on absorption

Therapeutic Delivery

Volumn 3, Issue 5, 2012, Pages 575-578

  Connor, Alyson ^a  

^a Quotient Clinical   (United Kingdom)

Author keywords

absorption; GI tract; modified release; permeability; solubility

Indexed keywords

DRUG;

ACCURACY; ANALYTICAL EQUIPMENT; COMPUTER ANALYSIS; DIGESTIVE TRACT INTUBATION; DRUG ABSORPTION; DRUG COATING; DRUG EXPOSURE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; EDITORIAL; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRACT FUNCTION; GASTROINTESTINAL TRANSIT; HUMAN; IMMEDIATE RELEASE FORMULATION; IN VIVO STUDY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REMOTE CONTROLLED CAPSULE; RISK ASSESSMENT; SMALL INTESTINE; STOMACH EMPTYING; STOMACH PH;

EID: 84861323742     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.34     Document Type: Editorial

References (10)

1. Morgan P, Van Der Graaf PH. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival. Drug Discov. Today doi:10.1016/j.drudis.2011.12.020 (2012) (Epub ahead of print).
2. Zhang GZ. Crystalline solid dispersions. Formulation strategies for poorly soluble drugs. Presented at: AAPS 45th Annual Arden Conference. West Point, NY, USA, 1-8 February 2010.
3. McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int. J. Pharm. 364(2), 213-226 (2008).
4. Sutton SC. The use of gastrointestinal intubation studies for controlled release development. Br. J. Clin. Pharm. 68(3), 342-354 (2009).
5. Wilding I, Hirst P, Connor A. Development of an engineering based capsule for human drug absorption studies. Pharm. Sci. Tech. Today 3(11), 385-392 (2000).
6. Reddy M, Connor A, Brennan BJ et al. Physiological modelling and assessment of regional drug bioavailability of danoprevir to determine whether a controlled released formulation is feasible. Biopharm. Drug Disp. 32(5), 261-275 (2011).
7. Basit AW, Podczeck F, Newton JM, Waddington WA, Ell PJ, Lacey LF. The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Eur. J. Pharm. Sci. 21(2-3), 179-189 (2004).
8. Bergstrand M, Söderlind E, Eriksson UG, Weitschies W, Karlsson MO. A semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulations. Pharm. Res. 29(2), 574-584 (2012).
9. Kararli TT. Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Disp. 16(5), 351-380 (1995).
10. Tannergren C, Bergendal A, Lennernäs H, Abrahamsson B. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. Mol. Pharm. 6(1), 60-73 (2009)